Cranberries don't kill the bacteria. They make them slippery. Uropathogenic E. coli grow tiny hooks that grip the bladder lining; the cranberry polyphenols called A-type proanthocyanidins (PACs) reach your urine and shorten those hooks so the bacteria can't latch on, and your next void flushes them. Two things follow. It's preventive only: once symptoms start, the infection is dug in and you need an antibiotic. And it works only on bacteria that infect by sticking, which is about 80% of infections (E. coli); for the rest it does little.
The evidence is unusually deep for a food. A Cochrane review of fifty trials in 8,857 people finds cranberry cuts recurrent infections in women by about a quarter over six months 1. A daily PAC-standardized juice cut clinically diagnosed infections in women by roughly 40% over 24 weeks 2. The effect is larger in children, and after pelvic radiation or bladder procedures it roughly halves.
The dose is why older trials disagreed. Split by how much PAC people actually got, everything above 36 mg a day drops infection risk about 18%; below it, no signal at all 3. The null studies were under-dosed, and the urology guidelines now point at the same standardized-dose principle 4. The heart and blood-sugar numbers on the package are real but small 5 — a free bonus if you already have the urinary reason to take it.
The number to hit is 36 mg of standardized A-type PACs a day. Everything below is how you deliver it.
What doesn't count: the juice cocktail (mostly sugar, PAC below the threshold) and sweetened dried cranberries (candy). Those are food; only the standardized form is the tool.
Other non-antibiotic options stack with cranberry: D-mannose (same anti-stick idea), vaginal estrogen (best evidence after menopause), methenamine hippurate (prescription, no resistance pressure), and basics like hydration and post-sex voiding. Continuous low-dose antibiotics work best but drive the resistance you'll live with later.
The fine print — when to skip it, and what people get wrong
"Drink juice when you feel one coming on" makes it worse: once symptomatic, you need an antibiotic, not juice. "Cocktail is cranberry": mostly sugar, PAC below threshold. "Two weeks did nothing": benefit accumulates over months.
- 1Williams G, Hahn D, Stephens JH, Craig JC, Hodson EM (2023). Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews. link
- 2Maki KC, Kaspar KL, Khoo C, Derrig LH, Schild AL, Gupta K (2016). Consumption of a cranberry juice beverage lowered the number of clinical urinary tract infection episodes in women with a recent history of urinary tract infection. American Journal of Clinical Nutrition. link
- 3Xia et al. (2024). Preventive effect of cranberries with high dose of proanthocyanidins on urinary tract infections: a meta-analysis and systematic review. Frontiers in Nutrition. link
- 4AUA (2022). Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2022 Amendment). link
- 5Novotny JA, Baer DJ, Khoo C, Gebauer SK, Charron CS (2015). Cranberry juice consumption lowers markers of cardiometabolic risk, including blood pressure and circulating C-reactive protein, triglyceride, and glucose concentrations in adults. Journal of Nutrition. link
- 6McHarg T, Rodgers A, Charlton K (2003). Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation. BJU International. link
Cranberries
Standardized 36 mg PAC capsules run ~$20–$30/month, ~$200–$300/year; whole cranberry powder cheaper per PAC delivered; pure unsweetened juice mid-range. Trivial to minor.
Daily capsule or daily juice serving; minimal behavioural change. Compliance over the 12–24 week onset window is the meaningful effort, not the moment-to-moment action.
Cochrane 2023 (50 RCTs, 8,857 participants) plus PAC-dose-stratified meta-analysis (Xia 2024) establish UTI prevention at ≥36 mg PAC/day; AUA 2022 Grade B recommendation. Cardiometabolic and microbiome signals are smaller RCTs. Strong on the central claim, weaker on the extended claims.
For the target population — women with recurrent UTIs, post-radiotherapy and post-transplant patients, children with recurrent UTIs — ≥36 mg PAC/day produces a clinically meaningful reduction in symptomatic UTI episodes (Cochrane NNT 17 women, 6 children; Williams 2023). Felt-experience translation: fewer episodes of dysuria, urgency, antibiotic courses. For non-susceptible adults the felt change is smaller.
Cardiometabolic risk-factor improvements (CRP -44% vs placebo, lower fasting glucose, triglycerides, diastolic BP; Novotny 2015) and FMD improvement (Heiss 2022) are real but modest, and hard endpoints (MI, stroke, mortality) are unstudied at long duration. Antibiotic-sparing in recurrent UTI also reduces downstream resistance harm, a small population-level longevity effect.
Modest indirect contribution via endothelial / microvascular effects from polyphenol metabolites; FMD improvement on whole-cranberry powder in healthy adults (Heiss 2022). Not a beauty intervention in any direct sense — the effect rides on general vascular health, slow and small.